Tag

Food and Drug Administration

• Propanc Biopharma skyrockets from pancreatic cancer drug breakthrough
  Rowan Dunne · Aug 28, 2026
• FDA panel to review GRAIL's Galleri multi-cancer blood test in September
  Joseph Morton · Aug 11, 2026
• McMaster surgeon develops AI tool to reduce invasive lung biopsies
  Joseph Morton · Sep 25, 2025
• Inovio advances DNA medicine for debilitating respiratory condition
  Joseph Morton · Aug 29, 2025
• Guardant Health gets Breakthrough Device Designation from FDA for cancer detection test
  Joseph Morton · Jun 24, 2025
• QuidelOrtho seeks FDA approval to complete acquisition of LEX Diagnostics
  Joseph Morton · Jun 6, 2025
• Johnson & Johnson subsidiary sued for USD$147M for breaching antitrust rules in California
  Joseph Morton · May 21, 2025
• Alibaba Group gets FDA nod for cancer detection tool
  Joseph Morton · Apr 24, 2025
• Soleno Therapeutics pulls in FDA nod for treatment for rare genetic disease
  Joseph Morton · Mar 27, 2025
• Median Technologies and European Investment Bank agrees to €37.5M loan
  Joseph Morton · Jan 28, 2025
• Breath Diagnostics onboards new president and closes critical financing
  Joseph Morton · Nov 1, 2024
• Scholar Rock stock skyrockets on successful phase 3 trial results
  Joseph Morton · Oct 7, 2024
• Breath Diagnostics takes aim at lung cancer with One Breath
  Joseph Morton · Aug 26, 2024
• FDA publishes first draft guidance document for psychedelics research
  Rowan Dunne · Jun 23, 2023
• FDA to reject medical device applications without cyberattack protection plans
  Joseph Morton · Mar 31, 2023
• Inspira Technologies seeks FDA approval for cardiopulmonary device
  Joseph Morton · Dec 20, 2022
• Inspire Medical Systems recruits top tier investor relations talent
  Joseph Morton · Aug 22, 2022
• MediPharm Labs to enter US pharmaceutical market via FDA drug registration
  Natalia Buendia Calvillo · Feb 23, 2022
• Delta-8 THC better harm-reduction tool than popular delta-9 THC, study suggests
  Natalia Buendia Calvillo · Nov 25, 2021
• US DEA set to authorize potent pot production for research
  Jared Gnam · May 19, 2021
• MindMed stock surges on Nasdaq listing approval
  Jared Gnam · Apr 23, 2021
• Low-THC weed led to poor results in major PTSD study
  Jared Gnam · Mar 30, 2021
• Charlotte's Web bounces back in Q4
  Jared Gnam · Mar 25, 2021
• US FDA unveils plan to gather 'real-world' data to fill CBD research gaps
  Jared Gnam · Jan 12, 2021
• Dousing strawberries in CBD oil reduces mould, extends shelf life: study
  Jared Gnam · Dec 10, 2020
• FDA's new draft guidelines could speed up CBD drug approvals
  Jared Gnam · Sep 29, 2020
• Canopy launches Martha Stewart CBD line in cluttered US market
  Jared Gnam · Sep 10, 2020
• Revive Therapeutics approved by FDA for Phase 3 trial of possible Covid-19 treatment
  Jared Gnam · Jul 31, 2020
• Canopy launches CBD website in US despite lack of FDA regulations
  Jared Gnam · Jul 27, 2020
• FDA issues cannabis research guidelines as CBD industry still hangs in limbo
  Jared Gnam · Jul 25, 2020
• Canopy to launch Martha Stewart CBD brand this fall
  Jared Gnam · Jun 26, 2020
• Charlotte's Web backs study on health outcomes of CBD
  Jared Gnam · Jun 10, 2020
• Aurora continues winning streak on US CBD deal
  Jared Gnam · May 21, 2020
• FDA's update on CBD regulations is 'frankly absurd'
  Michelle Gamage · Mar 7, 2020